Otom, Antonia F.
HRN: 26-64-06 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/07/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
02/07/2025
02/15/2025
IV
600mg
Qid
Bullous Impetigo
Checking Final Appropriateness
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes